Centene Corp stock gains 3.28 percent as earnings outlook improves

Published on 10/03/2026 at 21:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene Corp stock reached USD 62.99 on October 2, 2026, after Q2 adjusted EPS hit USD 2.51. Full-year adjusted EPS guidance rose above USD 4.80.

Isometrische 3D-Illustration der pharmazeutischen Lieferkette vom Hersteller zur Apotheke — Cencora Inc. Lieferkette US15135B1017 als isometrisches 3D-Diagramm von Hersteller über Lager bis Apotheke, Illustration mit AI erstellt.

Centene Corp stock (ISIN US15135B1017) closed at USD 62.99 on the NYSE on October 2, 2026, gaining 3.28 percent from a USD 60.99 prior close. The move came as the managed-care company’s latest earnings update pointed to a sharper 2026 profit recovery.

Q2 profit beat reset expectations

Centene reported Q2 2026 total revenue of USD 53.579 billion and diluted GAAP EPS of USD 2.19, according to StockTitan. The company’s adjusted diluted EPS reached USD 2.51, compared with a USD 0.89 consensus estimate, a USD 1.62 beat, according to Zacks.

The earnings mix matters because revenue growth alone does not capture the change in profitability. Zacks said revenue increased 9.9 percent year over year, while the adjusted EPS result improved from a USD 0.16 loss per share in the prior-year quarter.

Guidance now points higher

Centene lifted its full-year 2026 adjusted diluted EPS floor to above USD 4.80 from above USD 3.40, as management explained on the Q2 call carried by Fortune on July 28, 2026. Management also raised the Marketplace pretax margin outlook to 4.5 percent to 5 percent for 2026 from 3 percent previously.

The counterweight is membership pressure. Centene ended Q2 2026 with 12.1 million Medicaid members, while Marketplace membership stood at 3.5 million, according to the Fortune transcript. That combination leaves medical-cost execution and eligibility trends as important tests for the second half.

Analyst target remains above price

Cantor Fitzgerald maintained a Buy rating and a USD 75.00 price target on October 1, 2026, according to Investing.com. That target stood 19.07 percent above the October 2 price, while the broader average target on the page was USD 71.78.

Centene’s market capitalization was USD 31.1 billion on October 2, 2026, and its 52-week range was USD 31.63 to USD 69.63. The closing price therefore remained 9.54 percent below the yearly high, leaving the guidance upgrade and membership trend as the central valuation questions.